Infection in Critically Ill Pediatric Patients on Continuous Renal Replacement Therapy

Abstract

Introduction

Continuous renal replacement therapies (CRRT) are frequently used in critically ill children and may increase the risk of infection. However, the incidence, characteristics and prognosis of infection in critically ill children on CRRT have not been studied.

Methods

Data from a prospective, single-center register of critically ill children treated with CRRT was analyzed.

Results

55 children (40% under 1 year of age) were treated with CRRT between June 2008 and January 2012; 43 patients (78.2%) presented 1 or more infections. The most common condition of patients requiring CRRT was heart disease (69%). Infection occurred a median of 11 days after the initiation of CRRT (IQ range: 4 to 21 days). A total of 21 patients (48.8 %) developed 1 infection, 7 (16.2%) developed 2 infections and 15 (34.9%) developed 3 or more infections. The most frequent infection was catheter-related bacteremia, with no differences in catheter location. CRRT duration longer than 4.5 days was the only risk factor for infection. Patients with infection had a longer length of stay (LOS) in the Pediatric Intensive Care Unit (PICU) than patients without it (37.8 vs. 17.6, p = 0.019), but there were no differences in mortality (30.2% vs. 33.3%; p = 0.84).

Conclusions

Infection rate is high in critically ill children treated with CRRT. More than 4 days of CRRT increases the risk of infection. Infection in these patients entails a longer stay in the PICU but did not increase mortality.

Keywords

Acute kidney injury Continuous renal replacement therapy Extracorporeal membrane oxygenation Hemofiltration Infection

Get full access to this article

View all access options for this article.

References

Goldstein

S.L.

. Overview of pediatric renal replacement therapy in acute kidney injury. Semin Dial. 2009; 22(2): 180–184.

Walters

, Porter

, Brophy

P.D.

. Dialysis and pediatric acute kidney injury: choice of renal support modality. Pediatr Nephrol. 2009; 24(1): 37–48.

Santiago

M.J.

, López-Herce

, Urbano

. Clinical course and mortality risk factors in critically ill children requiring continuous renal replacement therapy. Intensive Care Med. 2010; 36(5): 843–849.

Reynvoet

, Vandijck

D.M.

, Blot

S.I.

. Epidemiology of infection in critically ill patients with acute renal failure. Crit Care Med. 2009; 37(7): 2203–2209.

Mehta

R.L.

, Bouchard

, Soroko

S.B.

. Program to Improve Care in Acute Renal Disease (PICARD) Study Group. Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease. Intensive Care Med. 2011; 37(2): 241–248.

Ostrowski

, Paterson

D.L.

, Lipman

, Udy

A.A.

. Blood culture collection in patients with acute kidney injury receiving renal replacement therapy: an observational study. Anaesth Intensive Care. 2012; 40(5): 813–819.

Hoste

E.A.

, Blot

S.I.

, Lameire

N.H.

, Vanholder

R.C.

, De Bacquer

, Colardyn

F.A.

. Effect of nosocomial bloodstream infection on the outcome of critically ill patients with acute renal failure treated with renal replacement therapy. J Am Soc Nephrol. 2004; 15(2): 454–462.

Centers for Disease Control and Prevention. Surveillance definition of healthcare-associated infection and criteria for specific types of infections in the acute care setting. https://www.cdc.gov/nhsn/pdfs/pscmanual/17pscnosinfdef_current.pdf. Accessed April 27, 2017.

Goldstein

, Giroir

, Randolph

. International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005; 6(1): 2–8.

10.

Aronoff

G.R.

, Bennett

W.M.

, Berns

J.S.

. Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children. 5th ed. American College of Physicians–American Society of Internal Medicine, Philadelphia, PA; 2007.

11.

Doyle

J.S.

, Buising

K.L.

, Thursky

K.A.

, Worth

L.J.

, Richards

M.J.

. Epidemiology of infections acquired in intensive care units. Semin Respir Crit Care Med. 2011; 32(2): 115–138.

12.

Vincent

J.L.

, Sakr

, Sprung

C.L.

. Sepsis Occurrence in Acutely III Patients Investigators. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006; 34(2): 344–353.

13.

Bajwa

, Kinsey

G.R.

, Okusa

M.D.

. Immune mechanisms and novel pharmacological therapies of acute kidney injury. Curr Drug Targets. 2009; 10(12): 1196–1204.

14.

Castillo

, Santiago

M.J.

, López-Herce

. Nutritional status and clinical outcome of children on continuous renal replacement therapy: a prospective observational study. BMC Nephrol. 2012; 13: 125.

15.

Fiaccadori

, Maggiore

, Giacosa

. Enteral nutrition in patients with acute renal failure. Kidney Int. 2004; 65(3): 999–1008.

16.

Thakar

C.V.

, Yared

J.P.

, Worley

, Cotman

, Paganini

E.P.

. Renal dysfunction and serious infections after open-heart surgery. Kidney Int. 2003; 64(1): 239–246.

17.

Parienti

J.J.

, Dugué

A.E.

, Daurel

. Members of the Cathedia Study Group. Continuous renal replacement therapy may increase the risk of catheter infection. Clin J Am Soc Nephrol. 2010; 5(8): 1489–1496.

18.

Guembe

, Pérez-Parra

, Gómez

. GEIDI Study Group. Impact on knowledge and practice of an intervention to control catheter infection in the ICU. Eur J Clin Microbiol Infect Dis. 2012; 31(10): 2799–2808.

19.

Santiago

M.J.

, López-Herce

, Urbano

. Complications of continuous renal replacement therapy in critically ill children: a prospective observational evaluation study. Crit Care. 2009; 13(6): R184.

20.

Parienti

J.J.

, Thirion

, Mégarbane

. Members of the Cathedia Study Group. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA. 2008; 299(20): 2413–2422.

21.

Vinsonneau

, Camus

, Combes

. Hemodiafe Study Group. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet. 2006; 368(9533): 379–385.

22.

Polderman

K.H.

. Is therapeutic hypothermia immunosuppressive? Crit Care. 2012; 16(Suppl 2): A8.

23.

Kamps

, Bisschops

L.A.

, van der Hoeven

J.G.

, Hoedemaekers

C.W.

. Hypothermia does not increase the risk of infection: a case control study. Crit Care. 2011; 15(1): R48.

24.

Mencía

, Berroya

, López-Herce

, Botrán

, Urbano

, Carrillo

. [Effects of induced hypothermia in critically ill children]. Med Intensiva. 2010; 34(6): 363–369.

25.

Paden

M.L.

, Warshaw

B.L.

, Heard

M.L.

, Fortenberry

J.D.

. Recovery of renal function and survival after continuous renal replacement therapy during extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2011; 12(2): 153–158.

26.

Askenazi

D.J.

, Ambalavanan

, Hamilton

. Acute kidney injury and renal replacement therapy independently predict mortality in neonatal and pediatric noncardiac patients on extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2011; 12(1): e1–e6.